Showing results (1151-1160 of 1,655) with videos related to
Sort By:
Pageof 166
Nano Letters|March 13, 2026
In Situ Polymerized "Solvated-Ionic-Liquid in Oligomer" Composite Electrolyte with Multiscale Anion Immobilization for Solid-State Lithium-Metal BatteriesEn-De Fu, Fan Yang, Ya-Ting Zhang, et al.ACS Omega|July 24, 2023
Siliceous Origin of the Cambrian Qiongzhusi Formation Shale in the Middle Part of the Upper Yangtze Platform: Significance of Organic Matter EnrichmentXiwei Wang, Jinchuan Zhang, Rongrong Zhao, et al.Nature Communications|January 29, 2025
VSTM2L protects prostate cancer cells against ferroptosis via inhibiting VDAC1 oligomerization and maintaining mitochondria homeostasisJuan Yang, Xiao Lu, Jing-Lan Hao, et al.Pancreas|February 13, 2020
Proceedings of the 3rd International Conference for Cancer Metabolism and Therapy, October 12-14, 2018, Shanghai, ChinaGary Guishan Xiao, Zhigang Zhang, Bin Lu, et al.Proceedings of the National Academy of Sciences of the United States of America|February 17, 2019
E-protein regulatory network links TCR signaling to effector Treg cell differentiationXiaojuan Han, Huarong Huang, Ping Gao, et al.BMC Nephrology|August 10, 2019
Admission serum sodium and potassium levels predict survival among critically ill patients with acute kidney injury: a cohort studyXu-Ping Gao, Chen-Fei Zheng, Min-Qi Liao, et al.Bioorganic Chemistry|August 31, 2025
Design, synthesis, and biological evaluation of dual-site HIV-1 inhibitors simultaneously targeting the NNRTI binding pocket and an adjacent site with favorable resistance profilesXiangkai Ji, Xiangyi Jiang, Xing Huang, et al.International Journal of Molecular Sciences|January 25, 2012
Combined pharmacophore modeling, docking, and 3D-QSAR studies of PLK1 inhibitorsShuai Lu, Hai-Chun Liu, Ya-Dong Chen, et al.Blood|October 28, 2004
Long-term pharmacologically regulated expression of erythropoietin in primates following AAV-mediated gene transferVictor M Rivera, Guang-ping Gao, Rebecca L Grant, et al.Zhonghua Nan Ke Xue = National Journal of Andrology|January 23, 2009
[Effectiveness and safety of naftopidil for benign prostatic hyperplasia patients with overactive bladder symptoms]Jing-ping Ge, Jun Gong, Hong-qing Ma, et al.Pageof 166